Research & Development
Scientific Overview
Scientific Presentations
Scientific Advisory Board
Clinical Studies
Clinical Trial Participation
Clinical Trial Sites
Pre-Clinical
Trials
Product Pipeline
Scientific Reports
 |
||||||||||
 |
 |
|||||||||
 |
 |
 |
 |
 |
||||||
 |
 |
|||||||||
 |
||||||||||
 |
||||||||||
 |
||||||||||
 |
||||||||||
 |
||||||||||
 |
Product Pipeline as of October 2007 | |||||||||
|
While the FDA ultimately determines the course and timing of clinical trials, this timeline represents an estimate as of October 2007 as to when certain research milestones could be achieved in the development of those applications. The pipeline below is subject to change at any time and is likely to change. Actual results may differ materially. It is provided for information purposes only. Investment decisions should not be made based on the timeline. CVBT does not undertake to update the timeline on this web site. This information is only an estimate as of October 2007. Enlarge Product Pipeline: [pdf] [jpg]
Use of
this site constitutes agreement to our Terms and Conditions Some content on this site requires the free Adobe
Reader. | ||||||||||
 |
||||||||||
 |
|
|
|
|
|
|
|
|
|
|
12/11/2008
CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
11/13/2008
CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial